IRTC IRhythm Technologies Inc.

iRhythm Technologies to Present at the 40th Annual Canaccord Genuity Global Growth Conference

iRhythm Technologies to Present at the 40th Annual Canaccord Genuity Global Growth Conference

SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 40th Annual Canaccord Genuity Global Growth Conference in Boston, MA.

iRhythm’s management is scheduled to present on Thursday, August 13, 2020 at 11:30 a.m. Eastern Time.  Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: .

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Investor Relations Contact

Lynn Pieper Lewis or Leigh Salvo

(415) 937-5404





Media Contact

Saige Smith 

(262) 289-7065

EN
29/07/2020

Underlying

IRTCIRhythm Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE
Free
IRTC IRhythm Technol...

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s...

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using the Zio® ambulatory ECG portfolio.1,2Chief Medical Officer Mintu Turakhia, MD, MS, delivered the 57th Annual Louis F. Bishop Keynote on scaling AI in cardiology and translating advances into clinical practice.iRhythm Academy launch expands access to clinician education at scale i...

March 30, 2026 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Holdings Appoints Jason Patten to its Board of Directors

iRhythm Holdings Appoints Jason Patten to its Board of Directors SAN FRANCISCO, March 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, is pleased to announce the appointment of Jason Patten to its Board of Directors, effective March 12, 2026. Mr. Patten brings decades of strategic leadership in healthcare, reinforcing iRhythm’s commitment to innovation, operational excellence, and long-term growth. “We are thrilled to welcome Jason Patten to our Board ...

March 12, 2026 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue of $208.9 million, a 27.1% increase compared to fourth quarter 2024Gross margin of 70.9%, a 90-basis point increase compared to fourth quarter 2024Net income of $5.6...

February 19, 2026 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and...

February 5, 2026 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 High...

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exc...

January 12, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch